Int J Oral Maxillofac Implants. 2021 Jan-Feb;36(1):21-29. doi: 10.11607/jomi.8417.
To assess the postoperative complications and outcome (implant survival) of quad zygomatic implants inserted in patients with edentulism and severely atrophic maxillae.
Two independent reviewers conducted an electronic search of the literature (PubMed, Scopus, EBSCO, Web of Science) from January 2000 to February 2019. The inclusion criteria were articles published in English reporting data of at least five patients with severely atrophic edentulous maxillae undergoing placement of four zygomatic implants without additional insertion of standard implants, with a minimum of 6 months of follow-up. Data extracted included number of patients, characteristics of the maxillary defect, number of zygomatic implants, implant details, surgical procedure, prosthetic rehabilitation, postoperative complications, survival rate, and length of follow-up after definitive prosthesis delivery.
Eleven studies with 166 patients were included. The heterogeneity among studies was not significant. The pooled incidence rates of complications were as follows: sinusitis 12% (95% confidence interval [CI]: 4% to 23%), malposition and surgical guiding failure 11% (95% CI: 3% to 21%), local infection/injury 10% (95% CI: 3% to 18%), and prosthetic complications 5% (95% CI: 0% to 13%). The implant survival rate ranged between 95.8% and 100%, and the pooled implant survival rate in the meta-analysis was 98% (95% CI: 97% to 99%).
Quad zygomatic implants inserted in patients with severely atrophic edentulous maxillae have a high implant survival rate, but the incidence of complications should not be underestimated.
评估在无牙颌和严重上颌萎缩患者中植入四枚颧骨种植体的术后并发症和结果(种植体存活率)。
两位独立的审查员对 2000 年 1 月至 2019 年 2 月的文献进行了电子搜索(PubMed、Scopus、EBSCO、Web of Science)。纳入标准为发表在英语期刊上的文章,报告了至少 5 例严重上颌无牙颌患者的资料,这些患者接受了 4 枚颧骨种植体的植入,未额外植入标准种植体,随访时间至少 6 个月。提取的数据包括患者数量、上颌骨缺损特征、颧骨种植体数量、种植体详细信息、手术过程、修复体的修复、术后并发症、存活率以及最终修复体交付后的随访时间长度。
纳入了 11 项研究共 166 例患者。研究之间的异质性不显著。并发症的汇总发生率如下:窦炎 12%(95%置信区间 [CI]:4%至 23%)、位置不当和手术引导失败 11%(95% CI:3%至 21%)、局部感染/损伤 10%(95% CI:3%至 18%)和修复体并发症 5%(95% CI:0%至 13%)。种植体存活率在 95.8%至 100%之间,荟萃分析中的种植体总存活率为 98%(95% CI:97%至 99%)。
在严重上颌萎缩的无牙颌患者中植入四枚颧骨种植体具有较高的种植体存活率,但不应低估并发症的发生率。